- ULTOMIRIS is a prescription medicine used to treat adults with a disease called generalized Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive1. It is a C5 inhibitor that binds to and blocks C5, which is part of the complement system that contributes to damaging muscle cells in gMG2. This results in damage and inflammation that interrupt nerve signals, causing gMG symptoms like muscle weakness2.Learn more:✕This summary was generated using AI based on multiple online sources. To view the original source information, use the "Learn more" links.ULTOMIRIS is a prescription medicine used to treat adults with a disease called generalized Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. It is not known if ULTOMIRIS is safe and effective for the treatment of gMG in children.ultomiris.com/gmgULTOMIRIS is a C5 inhibitor—it binds to and blocks C5, which is part of the complement system that contributes to damaging your muscle cells in gMG. This results in damage and inflammation that interrupt your nerve signals, causing gMG symptoms like the muscle weakness you may feel.ultomiris.com/gmg/pdfs/ULTOMIRIS-PATIENT-BR…
- People also ask
Generalized Myasthenia Gravis | ULTOMIRIS® (ravulizumab-cwvz)
WEBULTOMIRIS is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. It is FDA approved for adults with anti-AChR antibody-positive generalized myasthenia gravis (gMG), a rare autoimmune disease …
What is gMG?
ULTOMIRIS is a prescription medicine used to treat adults with a disease called …
How ULTOMIRIS® Works
ULTOMIRIS is a prescription medicine used to treat adults with a disease called …
See results only from ultomiris.com
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for adults …
WEBApr 28, 2022 · First and only long-acting C5 complement inhibitor to demonstrate clinical improvement in patients with generalized myasthenia gravis. ULTOMIRIS showed …
Generalized Myasthenia Gravis | ULTOMIRIS® (ravulizumab-cwvz) …
WEBLearn about ULTOMIRIS, a treatment for generalized myasthenia gravis (gMG). Please see Important Safety Information and full Prescribing Information, including Boxed …
Dosing | ULTOMIRIS® (ravulizumab-cwvz) | gMG
WEBThe recommended weight-based dosing regimen in adult patients with generalized myasthenia gravis (gMG) (≥40 kg [88 lb]) consists of a loading dose followed 2 weeks …
Ultomiris | European Medicines Agency
WEBJul 11, 2019 · Generalised myasthenia gravis. Ultomiris was compared with placebo (a dummy treatment) in one main study involving 175 adult patients, who had symptoms …
Ravulizumab (Ultomiris) - NCBI Bookshelf
WEBWhat Is Generalized Myasthenia Gravis?: MG is a condition that causes muscle weakness. In some patients, symptoms remain exclusively to the eyes (ocular MG); …
Terminal Complement Inhibitor Ravulizumab in …
WEBApr 26, 2022 · Generalized myasthenia gravis (gMG) is a rare, chronic, and debilitating autoimmune disease. Activation of the complement system by autoantibodies against the postsynaptic acetylcholine...
Ultomiris: Uses, Dosage, Side Effects, Warnings
WEBApr 2, 2024 · Ultomiris is an injectable complement inhibitor that may treat myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. It affects your immune system and …
Related searches for ultomiris myasthenia gravis
- Some results have been removed
Skip to content
